The Vax Files20 Jan 2021

5. The Second Wave of Vaccines

This fifth episode takes a look at some of the next vaccines in the development pipeline that could be equally important when it comes to ending the pandemic with a selection of different vaccines. We’ll look at some of the challenges to continue ongoing clinical trials now that vaccines are already publicly available. Experts discuss GSK and Sanofi’s recombinant protein vaccine that had some disappointing interim results in December, and they also discuss why Australia's now abandoned vaccine was triggering false positives for HIV. We also take a quick glimpse at the inactivated vaccines coming out of China, and the future potential of DNA vaccines that use special devices. Finally we take a look further down the road to whether developing and manufacturing Covid-19 vaccines might be economically viable for smaller players in the race in the long term. Expert Guests:

-- Reynald Castaneda is the Clinical Trials Editor of GlobalData Media in London, covering drug development for investors and the pharmaceutical industry.

-- Dr Yves Van Laethem is a retired virologist from Centre Hospitalier Universitaire Saint-Pierre and is currently the spokesperson for the fight against coronavirus in Belgium.
-- Dr Sam Sun is a resident physician at the Baylor College of Medicine and Director of InDemic, a non-profit research tool providing expert knowledge and analytics on the management of the Covid-19 pandemic.

-- Dr Deborah Fuller is a Professor of Microbiology at The University of Washington School of Medicine. A veteran vaccinologist and researcher, she has been working on vaccine development for the last 30 years with specific research around DNA and RNA technologies.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(17)

16. Future Pipeline and Global Outlook

Nearly two years after Covid-19 was first detected in Wuhan, the world is still very much in a pandemic. The toughest phase may behind us, but we are still faced with the possibility of new variants o...

1 Dec 202136min

15. Virus Evolution and Vaccine Pressure

As the world tries to take a hold over the delta variant, we're all watching and waiting to see if the virus is going to evolve into something new. There are fears that natural selection could potenti...

24 Nov 202132min

14. Vaccine Policies: Boosters and Mandates

As governments around the world try to get their countries and economies back on track, they are starting to desperately implement a number of vaccine policies that have sometimes been questioned by s...

17 Nov 202132min

13. Protecting Our Children

Vaccination in children has fueled a global expert debate specifically around the risk benefit consideration that some may find acceptable and others may find questionable. While children were largely...

10 Nov 202134min

12. Real World Safety

With around 7 billion doses administered, the vaccines have largely been proven safe, but there are still major concerns around rare serious side-effects and long term safety unknowns. Experts discuss...

3 Nov 202132min

11. Real World Effectiveness

Since the last episode in February, a lot has happened with the vaccination rollout -- so we're back for a few more episodes. But we've changed our name from The CoVax Files to The Vax Files, which wa...

27 Okt 202132min

10. The Last Lingering Questions

In this final and tenth episode, we'll tackle some of the last lingering questions that we all have around the vaccines and how the future might look as we navigate these uncharted pandemic waters. Ex...

24 Feb 202138min

9. The New Variant Drama

In this ninth episode, we'll tackle the different conundrums we face with the emergence of new and highly transmissible SARS-COV-2 variants. Get ready to delve into some thought provoking scientific c...

17 Feb 202135min